Literature DB >> 21196221

Myb proteins: angels and demons in normal and transformed cells.

Ye Zhou1, Scott A Ness.   

Abstract

A key regulator of proliferation, differentiation and cell fate, the c-Myb transcription factor regulates the expression of hundreds of genes and is in turn regulated by numerous pathways and protein interactions. However, the most unique feature of c-Myb is that it can be converted into an oncogenic transforming protein through a few mutations that completely change its activity and specificity. The c-Myb protein is a myriad of interactions and activities rolled up in a protein that controls proliferation and differentiation in many different cell types. Here we discuss the background and recent progress that have led to a better understanding of this complex protein, and outline the questions that have yet to be answered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196221      PMCID: PMC3570128          DOI: 10.2741/3738

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  210 in total

1.  Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription.

Authors:  J Soret; M Vellard; C Martinerie; B Perbal
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

2.  c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL.

Authors:  Joan Yuan; Rowena B Crittenden; Timothy P Bender
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

3.  Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins.

Authors:  K Weston
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

4.  Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.

Authors: 
Journal:  Cancer Control       Date:  1998-03       Impact factor: 3.302

5.  Detection of proteins that bind to the leucine zipper motif of c-Myb.

Authors:  D Favier; T J Gonda
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

6.  Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper.

Authors:  T Nomura; N Sakai; A Sarai; T Sudo; C Kanei-Ishii; R G Ramsay; D Favier; T J Gonda; S Ishii
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  Melanocyte fate in neural crest is triggered by Myb proteins through activation of c-kit.

Authors:  V Karafiat; M Dvorakova; P Pajer; V Cermak; M Dvorak
Journal:  Cell Mol Life Sci       Date:  2007-11       Impact factor: 9.261

8.  The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

Authors:  Emmanuelle Clappier; Wendy Cuccuini; Anna Kalota; Antoine Crinquette; Jean-Michel Cayuela; Willem A Dik; Anton W Langerak; Bertrand Montpellier; Bertrand Nadel; Pierre Walrafen; Olivier Delattre; Alain Aurias; Thierry Leblanc; Hervé Dombret; Alan M Gewirtz; André Baruchel; Francois Sigaux; Jean Soulier
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

9.  c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.

Authors:  Elaine Y Chung; Michael Dews; Diana Cozma; Duonan Yu; Erik A Wentzel; Tsung-Cheng Chang; Janell M Schelter; Michele A Cleary; Joshua T Mendell; Andrei Thomas-Tikhonenko
Journal:  Cancer Biol Ther       Date:  2008-11-04       Impact factor: 4.742

10.  Coordination of erythropoiesis by the transcription factor c-Myb.

Authors:  Alexandros Vegiopoulos; Paloma García; Nikla Emambokus; Jon Frampton
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

View more
  30 in total

1.  MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.

Authors:  Xinzhen Guo; Jie Zhang; Jianfeng Pang; Sheng He; Guojun Li; Yang Chong; Chao Li; Zhijian Jiao; Shiqian Zhang; Ming Shao
Journal:  Tumour Biol       Date:  2016-01-14

2.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

3.  c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.

Authors:  Shawn P Fahl; Andrea R Daamen; Rowena B Crittenden; Timothy P Bender
Journal:  J Immunol       Date:  2018-04-13       Impact factor: 5.422

4.  O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1.

Authors:  Huabei Guo; Bing Zhang; Alison V Nairn; Tamas Nagy; Kelley W Moremen; Phillip Buckhaults; Michael Pierce
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

5.  Editorial: Targeting MYB Oncogene Expression in Adenoid Cystic Carcinoma.

Authors:  Scott A Ness
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

6.  MicroRNA-548c-3p inhibits T98G glioma cell proliferation and migration by downregulating c-Myb.

Authors:  Jianyi Lu; Min Zhang; Xiao Yang; Tong Cui; Jinpo Dai
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

7.  Heterologous expression of AtMYB12 in kale (Brassica oleracea var. acephala) leads to high flavonol accumulation.

Authors:  Mika Lännenpää
Journal:  Plant Cell Rep       Date:  2014-05-04       Impact factor: 4.570

8.  miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb.

Authors:  Zeyu Chen; Erietta Stelekati; Makoto Kurachi; Sixiang Yu; Zhangying Cai; Sasikanth Manne; Omar Khan; Xiaolu Yang; E John Wherry
Journal:  Cell Rep       Date:  2017-09-12       Impact factor: 9.423

9.  Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Authors:  Coralie Hoareau-Aveilla; Thibaud Valentin; Camille Daugrois; Cathy Quelen; Géraldine Mitou; Samuel Quentin; Jinsong Jia; Salvatore Spicuglia; Pierre Ferrier; Monica Ceccon; Sylvie Giuriato; Carlo Gambacorti-Passerini; Pierre Brousset; Laurence Lamant; Fabienne Meggetto
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

10.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Authors:  Kathryn J Brayer; Candace A Frerich; Huining Kang; Scott A Ness
Journal:  Cancer Discov       Date:  2015-12-02       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.